Alexandra Phan

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

J. Diallo, Stephen Boulton, S. Paludan, 2022, Molecular Therapy.

Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron

W. Stanford, J. Dikeakos, J. Prévost, 2022, iScience.

Identification of a SARS-CoV-2 host metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 and variants of concern Alpha, Delta, and Omicron

W. Stanford, J. Dikeakos, J. Prévost, 2022, bioRxiv.

Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments

M. Côté, D. Kobasa, P. Giguère, 2021, PLoS pathogens.